To confirm the efficacy of newly synthesized compounds in vivo, the selected compounds were tested in a Drosophila model of HD, with transgenic flies that express full-length human pathogenic cDNA, encoding a mutated HTT protein [9,24]. This evidence concerns the gene HTT and Huntington disease.